Alpha Mark Advisors, LLC Astrazeneca PLC Transaction History
Alpha Mark Advisors, LLC
- $231 Million
- Q4 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 342 shares of AZN stock, worth $25,786. This represents 0.01% of its overall portfolio holdings.
Number of Shares
342
Previous 342
-0.0%
Holding current value
$25,786
Previous $27,000
18.52%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...